Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/66380
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Fred K. | - |
dc.contributor.author | McLenachan, Samuel | - |
dc.contributor.author | Edel, Michael John | - |
dc.contributor.author | Da Cruz, Lyndon | - |
dc.contributor.author | Coffey, Peter J. | - |
dc.contributor.author | Mackey, David A. | - |
dc.date.accessioned | 2015-07-16T08:28:21Z | - |
dc.date.available | 2015-07-16T08:28:21Z | - |
dc.date.issued | 2014-12-19 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | http://hdl.handle.net/2445/66380 | - |
dc.description.abstract | For many decades, we have relied on immortalised retinal cell lines, histology of enucleated human eyes, animal models, clinical observation, genetic studies and human clinical trials to learn more about the pathogenesis of retinal diseases and explore treatment options. The recent availability of patient-specific induced pluripotent stem cells (iPSC) for deriving retinal lineages has added a powerful alternative tool for discovering new disease-causing mutations, studying genotype-phenotype relationships, performing therapeutics-toxicity screening and developing personalised cell therapy. This review article provides a clinical perspective on the current and potential benefits of iPSC for managing the most common blinding diseases of the eye: inherited retinal diseases and age-related macular degeneration. | - |
dc.format.extent | 31 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.3390/jcm3041511 | - |
dc.relation.ispartof | Journal of Clinical Medicine, 2014, vol. 4, num. 3, p. 1511-1541 | - |
dc.relation.uri | http://dx.doi.org/10.3390/jcm3041511 | - |
dc.rights | cc-by (c) Chen, Fred Kuanfu et al., 2014 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Ciències Fisiològiques) | - |
dc.subject.classification | Cèl·lules mare | - |
dc.subject.classification | Malalties de la retina | - |
dc.subject.classification | Degeneració (Patologia) | - |
dc.subject.classification | Genètica molecular | - |
dc.subject.classification | Trasplantament d'òrgans | - |
dc.subject.other | Stem cells | - |
dc.subject.other | Retinal diseases | - |
dc.subject.other | Degeneration (Pathology) | - |
dc.subject.other | Molecular genetics | - |
dc.subject.other | Transplantation of organs | - |
dc.title | iPS Cells for Modelling and Treatment of Retinal Diseases | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 650730 | - |
dc.date.updated | 2015-07-16T08:28:21Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 26237613 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Fisiològiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
650730.pdf | 2.39 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License